BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Seattle - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Seattle
X-ORIGINAL-URL:https://scienceinseattle.com
X-WR-CALDESC:Events for Science in Seattle
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210208T080000
DTEND;TZID=America/Vancouver:20210212T170000
DTSTAMP:20260718T114325
CREATED:20210208T181911Z
LAST-MODIFIED:20210208T181911Z
UID:11441-1612771200-1613149200@scienceinseattle.com
SUMMARY:Transplantation & Cellular Therapy
DESCRIPTION:Follow Fred Hutch at TCT: #TCTM21\n\n\n\n\n\n\n\nFred Hutch scientists are presenting new research findings at the Transplantation & Cellular Therapy (TCT) Meetings. The TCT represents the combined annual meetings of the American Society for Blood and Marrow Transplantation (ASBMT) and the Center for International Blood & Marrow Transplant Research (CIBMTR). \nThe meeting features the E. Donnall Thomas Lecture\, named after the late Nobel laureate who pioneered bone marrow transplantation at Fred Hutch. The honor recognizes an eminent physician or scientist who has contributed meritoriously to the advancement of knowledge in blood and marrow transplantation. \nFred Hutch and Seattle Cancer Care Alliance will co-host a virtual booth at the meeting.
URL:https://scienceinseattle.com/event/transplantation-cellular-therapy/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210208T080000
DTEND;TZID=America/Vancouver:20210212T170000
DTSTAMP:20260718T114325
CREATED:20210208T181911Z
LAST-MODIFIED:20210208T181911Z
UID:25669-1612771200-1613149200@scienceinseattle.com
SUMMARY:Transplantation & Cellular Therapy
DESCRIPTION:Follow Fred Hutch at TCT: #TCTM21\n\n\n\n\n\n\n\nFred Hutch scientists are presenting new research findings at the Transplantation & Cellular Therapy (TCT) Meetings. The TCT represents the combined annual meetings of the American Society for Blood and Marrow Transplantation (ASBMT) and the Center for International Blood & Marrow Transplant Research (CIBMTR). \nThe meeting features the E. Donnall Thomas Lecture\, named after the late Nobel laureate who pioneered bone marrow transplantation at Fred Hutch. The honor recognizes an eminent physician or scientist who has contributed meritoriously to the advancement of knowledge in blood and marrow transplantation. \nFred Hutch and Seattle Cancer Care Alliance will co-host a virtual booth at the meeting.
URL:https://scienceinseattle.com/event/transplantation-cellular-therapy-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210208T080000
DTEND;TZID=America/Vancouver:20210212T170000
DTSTAMP:20260718T114325
CREATED:20210208T181911Z
LAST-MODIFIED:20210208T181911Z
UID:26634-1612771200-1613149200@scienceinseattle.com
SUMMARY:Transplantation & Cellular Therapy
DESCRIPTION:Follow Fred Hutch at TCT: #TCTM21\n\n\n\n\n\n\n\nFred Hutch scientists are presenting new research findings at the Transplantation & Cellular Therapy (TCT) Meetings. The TCT represents the combined annual meetings of the American Society for Blood and Marrow Transplantation (ASBMT) and the Center for International Blood & Marrow Transplant Research (CIBMTR). \nThe meeting features the E. Donnall Thomas Lecture\, named after the late Nobel laureate who pioneered bone marrow transplantation at Fred Hutch. The honor recognizes an eminent physician or scientist who has contributed meritoriously to the advancement of knowledge in blood and marrow transplantation. \nFred Hutch and Seattle Cancer Care Alliance will co-host a virtual booth at the meeting.
URL:https://scienceinseattle.com/event/transplantation-cellular-therapy-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210211T160000
DTEND;TZID=America/Vancouver:20210211T170000
DTSTAMP:20260718T114325
CREATED:20210208T181510Z
LAST-MODIFIED:20210208T181510Z
UID:11431-1613059200-1613062800@scienceinseattle.com
SUMMARY:CFAR Seminar- The AMP Trials
DESCRIPTION:Start Date and Time\nFebruary 11\, 2021 – 4:00pm\n\n\nEnd Date and Time\nFebruary 11\, 2021 – 5:00pm\n\n\nSpeaker: Lawrence Corey\, MD\nPast President and Director\, Fred Hutch\nProfessor\, Vaccine and Infectious Disease Division\, Fred Hutch\nProfessor\, Medicine and Laboratory Medicine\, UW \nZoom – washington.zoom.us/j/91567478853 \nDr. Lawrence Corey will review the efficacy data from the Antibody Mediated Prevention (AMP) trials conducted by the HIV Vaccine Trials Network (HVTN) and the HIV Prevention Trials Network (HPTN) \n \nDr. Larry Corey is an internationally renowned expert in virology\, immunology and vaccine development\, and the former president and director of the Fred Hutchinson Cancer Research Center. His research focuses on herpes viruses\, HIV\, the novel coronavirus and other viral infections\, including those associated with cancer. He is principal investigator of the HIV Vaccine Trials Network\, or HVTN\, which conducts studies of HIV vaccines at over 80 clinical trials sites in 16 countries on five continents. Under his leadership\, the HVTN has become the model for global\, collaborative research. Dr. Corey is also the principal investigator of the Fred Hutch-based operations center of the COVID-19 Prevention Network (CoVPN) and co-leads the Network’s COVID-19 vaccine testing pipeline. The CoVPN is carrying out the large Operation Warp Speed portfolio of COVID-19 vaccines and monoclonal antibodies intended to protect people from COVID-19. \nDr. Corey is a member of the US National Academy of Medicine and the American Academy of Arts and Sciences\, and was the recipient of the Parran Award for his work in HSV-2\, the American Society of Microbiology Cubist Award for his work on antivirals\, and the University of Michigan Medical School Distinguished Alumnus Award. He is one of the most highly cited biomedical researchers in the last 20 years and is the author\, coauthor or editor of over 1000 scientific publications.
URL:https://scienceinseattle.com/event/cfar-seminar-the-amp-trials/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210211T160000
DTEND;TZID=America/Vancouver:20210211T170000
DTSTAMP:20260718T114326
CREATED:20210208T181510Z
LAST-MODIFIED:20210208T181510Z
UID:25666-1613059200-1613062800@scienceinseattle.com
SUMMARY:CFAR Seminar- The AMP Trials
DESCRIPTION:Start Date and Time\nFebruary 11\, 2021 – 4:00pm\n\n\nEnd Date and Time\nFebruary 11\, 2021 – 5:00pm\n\n\nSpeaker: Lawrence Corey\, MD\nPast President and Director\, Fred Hutch\nProfessor\, Vaccine and Infectious Disease Division\, Fred Hutch\nProfessor\, Medicine and Laboratory Medicine\, UW \nZoom – washington.zoom.us/j/91567478853 \nDr. Lawrence Corey will review the efficacy data from the Antibody Mediated Prevention (AMP) trials conducted by the HIV Vaccine Trials Network (HVTN) and the HIV Prevention Trials Network (HPTN) \n \nDr. Larry Corey is an internationally renowned expert in virology\, immunology and vaccine development\, and the former president and director of the Fred Hutchinson Cancer Research Center. His research focuses on herpes viruses\, HIV\, the novel coronavirus and other viral infections\, including those associated with cancer. He is principal investigator of the HIV Vaccine Trials Network\, or HVTN\, which conducts studies of HIV vaccines at over 80 clinical trials sites in 16 countries on five continents. Under his leadership\, the HVTN has become the model for global\, collaborative research. Dr. Corey is also the principal investigator of the Fred Hutch-based operations center of the COVID-19 Prevention Network (CoVPN) and co-leads the Network’s COVID-19 vaccine testing pipeline. The CoVPN is carrying out the large Operation Warp Speed portfolio of COVID-19 vaccines and monoclonal antibodies intended to protect people from COVID-19. \nDr. Corey is a member of the US National Academy of Medicine and the American Academy of Arts and Sciences\, and was the recipient of the Parran Award for his work in HSV-2\, the American Society of Microbiology Cubist Award for his work on antivirals\, and the University of Michigan Medical School Distinguished Alumnus Award. He is one of the most highly cited biomedical researchers in the last 20 years and is the author\, coauthor or editor of over 1000 scientific publications.
URL:https://scienceinseattle.com/event/cfar-seminar-the-amp-trials-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210211T160000
DTEND;TZID=America/Vancouver:20210211T170000
DTSTAMP:20260718T114326
CREATED:20210208T181510Z
LAST-MODIFIED:20210208T181510Z
UID:26631-1613059200-1613062800@scienceinseattle.com
SUMMARY:CFAR Seminar- The AMP Trials
DESCRIPTION:Start Date and Time\nFebruary 11\, 2021 – 4:00pm\n\n\nEnd Date and Time\nFebruary 11\, 2021 – 5:00pm\n\n\nSpeaker: Lawrence Corey\, MD\nPast President and Director\, Fred Hutch\nProfessor\, Vaccine and Infectious Disease Division\, Fred Hutch\nProfessor\, Medicine and Laboratory Medicine\, UW \nZoom – washington.zoom.us/j/91567478853 \nDr. Lawrence Corey will review the efficacy data from the Antibody Mediated Prevention (AMP) trials conducted by the HIV Vaccine Trials Network (HVTN) and the HIV Prevention Trials Network (HPTN) \n \nDr. Larry Corey is an internationally renowned expert in virology\, immunology and vaccine development\, and the former president and director of the Fred Hutchinson Cancer Research Center. His research focuses on herpes viruses\, HIV\, the novel coronavirus and other viral infections\, including those associated with cancer. He is principal investigator of the HIV Vaccine Trials Network\, or HVTN\, which conducts studies of HIV vaccines at over 80 clinical trials sites in 16 countries on five continents. Under his leadership\, the HVTN has become the model for global\, collaborative research. Dr. Corey is also the principal investigator of the Fred Hutch-based operations center of the COVID-19 Prevention Network (CoVPN) and co-leads the Network’s COVID-19 vaccine testing pipeline. The CoVPN is carrying out the large Operation Warp Speed portfolio of COVID-19 vaccines and monoclonal antibodies intended to protect people from COVID-19. \nDr. Corey is a member of the US National Academy of Medicine and the American Academy of Arts and Sciences\, and was the recipient of the Parran Award for his work in HSV-2\, the American Society of Microbiology Cubist Award for his work on antivirals\, and the University of Michigan Medical School Distinguished Alumnus Award. He is one of the most highly cited biomedical researchers in the last 20 years and is the author\, coauthor or editor of over 1000 scientific publications.
URL:https://scienceinseattle.com/event/cfar-seminar-the-amp-trials-3/
LOCATION:Online
END:VEVENT
END:VCALENDAR